{
    "Symbol": "IQV",
    "AssetType": "Common Stock",
    "Name": "IQVIA Holdings Inc",
    "Description": "IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",
    "CIK": "1478242",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TRADE & SERVICES",
    "Industry": "SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH",
    "Address": "4820 EMPEROR BLVD., DURHAM, NC, US",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "44076495000",
    "EBITDA": "2779000000",
    "PERatio": "31.4",
    "PEGRatio": "1.4",
    "BookValue": "36.83",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "7.7",
    "RevenuePerShareTTM": "83.16",
    "ProfitMargin": "0.0939",
    "OperatingMarginTTM": "0.144",
    "ReturnOnAssetsTTM": "0.0503",
    "ReturnOnEquityTTM": "0.228",
    "RevenueTTM": "15155000000",
    "GrossProfitTTM": "5028000000",
    "DilutedEPSTTM": "7.7",
    "QuarterlyEarningsGrowthYOY": "0.239",
    "QuarterlyRevenueGrowthYOY": "0.023",
    "AnalystTargetPrice": "274.27",
    "AnalystRatingStrongBuy": "7",
    "AnalystRatingBuy": "12",
    "AnalystRatingHold": "5",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "31.4",
    "ForwardPE": "22.57",
    "PriceToSalesRatioTTM": "2.908",
    "PriceToBookRatio": "6.74",
    "EVToRevenue": "3.764",
    "EVToEBITDA": "17.11",
    "Beta": "1.495",
    "52WeekHigh": "261.73",
    "52WeekLow": "167.42",
    "50DayMovingAverage": "222.2",
    "200DayMovingAverage": "223.64",
    "SharesOutstanding": "182300000",
    "DividendDate": "None",
    "ExDividendDate": "None"
}